MyFinsight
Home
Blog
About
Back
Income Statement
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)
source: myfinsight.com
Revenue
$4,022,763
(309.02%↑ Y/Y)
Gross profit
$2,578,171
(340.09%↑ Y/Y)
Cost of revenue
$1,444,592
(263.25%↑ Y/Y)
Net loss
-$2,905,473
(-122.51%↓ Y/Y)
Income (loss) from
operations
$565,977
(326.31%↑ Y/Y)
Total operating
expenses
$2,012,194
(140.72%↑ Y/Y)
Total other expense
-$3,471,450
(-228.83%↓ Y/Y)
Professional fee
$708,117
General and
administrative
$619,164
(198.47%↑ Y/Y)
Advertising and marketing
$546,603
(270.31%↑ Y/Y)
Depreciation and
amortization expense
$90,810
(65.61%↑ Y/Y)
Investor relations
$25,000
(-37.50%↓ Y/Y)
Officer compensation
$22,500
(0.00%↑ Y/Y)
Interest expense
$2,233,797
(111.66%↑ Y/Y)
Change in derivative
liabilities
-$1,237,653
(-377233.23%↓ Y/Y)
Back